Related Experiment Videos
Thrombotic thrombocytopenic purpura
1Departments of Pediatrics, Nephrology, Hematology+, Choithram Hospital and Research Centre, Indore 452 001, India.
Indian Pediatrics
|April 6, 2004
Summary
A child with thrombotic thrombocytopenic purpura (TTP) recovered after plasmapheresis. This condition involves microangiopathic hemolytic anemia and thrombocytopenia, and recent research highlights a key enzyme in its pathology.
Area of Science:
- Hematology
- Pediatric Medicine
- Pathophysiology
Background:
- Thrombotic thrombocytopenic purpura (TTP) is a rare, life-threatening disorder.
- It is characterized by microangiopathic hemolytic anemia, thrombocytopenia, neurological symptoms, and renal abnormalities.
- The underlying pathophysiology involves dysregulation of von Willebrand factor (vWF).
Purpose of the Study:
- To present a pediatric case of TTP.
- To review recent advancements in TTP understanding.
- To emphasize the role of ADAMTS13 in TTP pathogenesis.
Main Methods:
- Case report of a 6-year-old boy.
- Clinical presentation and diagnostic workup.
- Treatment with plasmapheresis.
- Literature review on TTP pathophysiology.
Main Results:
- The patient presented with severe microangiopathic hemolytic anemia, thrombocytopenia, altered sensorium, and bleeding.
- Dramatic clinical improvement was observed following plasmapheresis.
- Recent research underscores the critical role of ADAMTS13, a metalloprotease, in cleaving large von Willebrand factor multimers.
Conclusions:
- Plasmapheresis remains a cornerstone treatment for TTP.
- Understanding the role of ADAMTS13 is crucial for TTP diagnosis and management.
- Early recognition and prompt treatment are vital for favorable outcomes in pediatric TTP.